Genetic modifiers of carcinogen DNA adducts in target lung and peripheral blood mononuclear cells

Carcinogenesis

Volumn 31, Issue 12, 2010, Pages 2091-2096

  Lee, Mi Sun ^a   Su, Li ^a   Mark, Eugene J ^b   Wain, John C ^b   Christiani, David C ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; DNA; EPOXIDE HYDROLASE; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; GLUTATHIONE TRANSFERASE; PHOSPHORUS 32; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); XERODERMA PIGMENTOSUM GROUP D PROTEIN; XRCC1 PROTEIN;

AGED; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CANCER STAGING; DNA ADDUCT; DNA METHYLATION; DNA MODIFICATION; DNA REPAIR; EARLY CANCER; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HUMAN; HUMAN TISSUE; LUNG CANCER; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; CARCINOGENS; DNA ADDUCTS; DNA REPAIR; DNA-BINDING PROTEINS; ENDONUCLEASES; FEMALE; GENOTYPE; HUMANS; LEUKOCYTES, MONONUCLEAR; LUNG; LUNG NEOPLASMS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 78649778478     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq208     Document Type: Article

References (30)

1. Wiencke,J.K. (2002) DNA adduct burden and tobacco carcinogenesis. Oncogene, 21, 7376-7391.
2. Wiencke,J.K. et al. (1995) Correlation of DNA adducts in blood mononuclear cells with tobacco carcinogen-induced damage in human lung. Cancer Res., 55, 4910-4914.
3. Wiencke,J.K. et al. (1999) Early age at smoking initiation and tobacco carcinogen DNA damage in the lung. J. Natl Cancer Inst., 91, 614-619.
4. Peluso,M. et al. (2005) DNA adducts and lung cancer risk: a prospective study. Cancer Res., 65, 8042-8048.
5. Perera,F.P. et al. (2002) Associations between carcinogen-DNA damage, glutathione S-transferase genotypes, and risk of lung cancer in the prospective Physicians' Health Cohort Study. Carcinogenesis, 23, 1641-1646.
6. Tang,D. et al. (2001) Association between carcinogen-DNA adducts in white blood cells and lung cancer risk in the physicians health study. Cancer Res., 61, 6708-6712.
7. Bak,H. et al. (2006) Bulky DNA adducts as risk indicator of lung cancer in a Danish case-cohort study. Int. J. Cancer, 118, 1618-1622.
8. Cheng,Y.W. et al. (2000) DNA adduct level in lung tissue may act as a risk biomarker of lung cancer. Eur. J. Cancer, 36, 1381-1388.
9. Hou,S.M. et al. (1999) Hprt mutant frequency and aromatic DNA adduct level in non-smoking and smoking lung cancer patients and population controls. Carcinogenesis, 20, 437-444.
10. Wu,X. et al. (2004) Genetic susceptibility to tobacco-related cancer. Oncogene, 23, 6500-6523.
11. Vineis,P. et al. (2007) Genetic susceptibility according to three metabolic pathways in cancers of the lung and bladder and in myeloid leukemias in nonsmokers. Ann. Oncol., 18, 1230-1242.
12. Schwartz,A.G. et al. (2007) The molecular epidemiology of lung cancer. Carcinogenesis, 28, 507-518.
13. Gazdar,A.F. (2007) DNA repair and survival in lung cancer-the two faces of Janus. N. Engl. J. Med., 356, 771-773.
14. Jones,P.A. et al. (2002) The fundamental role of epigenetic events in cancer. Nat. Rev. Genet., 3, 415-428.
15. Shen,H. et al. (2001) Polymorphisms of methylene-tetrahydrofolate reductase and risk of lung cancer: a case-control study. Cancer Epidemiol. Biomarkers Prev., 10, 397-401.
16. Shi,Q. et al. (2005) Sex differences in risk of lung cancer associated with methylene-tetrahydrofolate reductase polymorphisms. Cancer Epidemiol. Biomarkers Prev., 14, 1477-1484.
17. Lee,M.S. et al. (2010) Synergistic effects of NAT2 slow and GSTM1 null genotypes on carcinogen DNA damage in the lung. Cancer Epidemiol. Biomarkers Prev., 19, 1492-14977.
18. Liu,G. et al. (2001) Differential association of the codon 72 p53 and GSTM1 polymorphisms on histological subtype of non-small cell lung carcinoma. Cancer Res., 61, 8718-8722.
19. Zhou,W. et al. (2002) Genetic polymorphisms in N-acetyltransferase-2 and microsomal epoxide hydrolase, cumulative cigarette smoking, and lung cancer. Cancer Epidemiol. Biomarkers Prev., 11, 15-21.
20. Zhou,W. et al. (2001) The interaction between microsomal epoxide hydrolase polymorphisms and cumulative cigarette smoking in different histological subtypes of lung cancer. Cancer Epidemiol. Biomarkers Prev., 10, 461-466.
21. Benjamini,Y. et al. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple teesting. J. R. Stat. Soc. Ser. B., 57, 289-300.
22. Bedard,L.L. et al. (2005) Susceptibility to aflatoxin B1-induced carcinogenesis correlates with tissue-specific differences in DNA repair activity in mouse and in rat. Cancer Res., 65, 1265-1270.
23. Thum,T. et al. (2006) Expression of xenobiotic metabolizing enzymes in different lung compartments of smokers and nonsmokers. Environ. Health Perspect., 114, 1655-1661.
24. Neumann,H.G. (2009) Risk assessment of chemical carcinogens and thresholds. Crit. Rev. Toxicol., 39, 449-461.
25. Poirier,M.C. et al. (1995) DNA adduct formation and tumorigenesis in mice during the chronic administration of 4-aminobiphenyl at multiple dose levels. Carcinogenesis, 16, 2917-2921.
26. Zhou,W. et al. (2004) Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy. Clin. Cancer Res., 10, 4939-4943.
27. Devlin,A.M. et al. (2004) Effect of Mthfr genotype on diet-induced hyperhomocysteinemia and vascular function in mice. Blood, 103, 2624-2629.
28. Yagi,S. et al. (2008) DNA methylation profile of tissue-dependent and differentially methylated regions (T-DMRs) in mouse promoter regions demonstrating tissue-specific gene expression. Genome Res., 18, 1969-1978.
29. Vaissiere,T. et al. (2009) Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors. Cancer Res., 69, 243-252.
30. Tang,D. et al. (1995) A molecular epidemiological case-control study of lung cancer. Cancer Epidemiol. Biomarkers Prev., 4, 341-346.